Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
132M
-
Number of holders
-
255
-
Total 13F shares, excl. options
-
65.9M
-
Shares change
-
+662K
-
Total reported value, excl. options
-
$6.21B
-
Value change
-
+$91.3M
-
Put/Call ratio
-
1.23
-
Number of buys
-
127
-
Number of sells
-
-110
-
Price
-
$94.14
Significant Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q4 2015
311 filings reported holding ALNY - ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2015.
ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) has 255 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.9M shares
of 132M outstanding shares and own 50.13% of the company stock.
Largest 10 shareholders include FMR LLC (12.7M shares), WELLINGTON MANAGEMENT GROUP LLP (10.7M shares), VANGUARD GROUP INC (5.05M shares), BAILLIE GIFFORD & CO (2.73M shares), Capital World Investors (1.94M shares), UBS ASSET MANAGEMENT AMERICAS INC (1.92M shares), BlackRock Institutional Trust Company, N.A. (1.77M shares), BlackRock Fund Advisors (1.73M shares), STATE STREET CORP (1.67M shares), and JENNISON ASSOCIATES LLC (1.49M shares).
This table shows the top 255 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.